Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction
Authors:
- Daphne MerkusDMDaphne Merkus
- Oana SoropOSOana Sorop
- Frans BoomsmaFBFrans Boomsma
- Dirk J. DunckerDDDirk J. Duncker
- 6 July 2006
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 574 (2) , 615-626
Abstract
We previously observed that pulmonary hypertension secondary to myocardial infarction (MI) in swine is characterized by elevated plasma endothelin (ET) levels and pulmonary vascular resistance (PVR). Consequently, we tested the hypothesis that an increased ET‐mediated vasoconstrictor influence contributes to secondary pulmonary hypertension after MI and investigated the involvement of ETAand ETBreceptor subtypes. Chronically instrumented swine with (MI swine;n= 25) or without (normal swine;n= 19) MI were studied at rest and during treadmill exercise (up to 4 km h−1), in the absence and presence of the ETAantagonist EMD 122946 or the mixed ETA/ETBantagonist tezosentan. In normal swine, exercise caused a small decrease in PVR. ETAblockade had no effect on PVR at rest or during exercise. Conversely, ETA/ETBblockade decreased PVR but only during exercise (at 4 km h−1, from 3.0 ± 0.1 to 2.3 ± 0.1 mmHg min l−1;P≤ 0.05). MI increased pulmonary arterial pressure and PVR both at rest and during exercise (bothP≤ 0.05). The increased pulmonary arterial pressure correlated with the increased plasma ET levels in resting MI swine (r= 0.71;P≤ 0.01). Furthermore, the pulmonary vasoconstrictor response to ET‐1 infusion was enhanced after MI (P≤ 0.05). ETA/ETBblockade decreased PVR in MI swine from 3.6 ± 0.3 to 3.1 ± 0.5 mmHg min l−1at rest and from 3.4 ± 0.3 to 2.4 ± 0.2 mmHg min l−1during exercise at 4 km h−1(bothP≤ 0.05). This increased response to mixed ETA/ETBblockade in MI compared to normal swine appeared to be the result of an increased ETA‐mediated vasoconstriction, as ETAblockade decreased PVR in MI swine from 3.4 ± 0.4 to 2.8 ± 0.2 mmHg min l−1at rest and from 3.1 ± 0.3 to 2.6 ± 0.2 mmHg min l−1at 4 km h−1(bothP≤ 0.05). In conclusion, increased plasma ET levels together with increased pulmonary resistance vessel responsiveness to ET result in an exaggerated pulmonary vasoconstrictor influence of ET in swine with a recent MI. This vasoconstrictor influence is the result of an emergent tonic ETA‐mediated vasoconstriction in addition to the exercise‐induced ETB‐mediated vasoconstriction that is already present in normal swine.Keywords
This publication has 51 references indexed in Scilit:
- Endothelin receptor antagonistsPharmacology & Therapeutics, 2006
- Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- STRIDE 1: Effects of the Selective ETA Receptor Antagonist, Sitaxsentan Sodium, in a Patient Population with Pulmonary Arterial Hypertension that meets Traditional Inclusion Criteria of Previous Pulmonary Arterial Hypertension TrialsJournal of Cardiovascular Pharmacology, 2004
- Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1Cardiovascular Research, 2004
- Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Contraction to big endothelin‐1, big endothelin‐2 and big endothelin‐3, and endothelin‐converting enzyme inhibition in human isolated bronchiBritish Journal of Pharmacology, 2000
- DOWN-REGULATION OF ETb RECEPTOR, BUT NOT ETa RECEPTOR, IN CONGESTIVE LUNG SECONDARY TO HEART FAILURE. ARE MARKED INCREASES IN CIRCULATING ENDOTHELIN-1 PARTLY ATTRIBUTABLE TO DECREASES IN LUNG ETb RECEPTOR-MEDIATED CLEARANCE OF ENDOTHELIN-1?Life Sciences, 1997
- Endothelin ETA- and ETB-Receptor-Mediated Vasoconstriction in Rat Pulmonary Arteries and ArteriolesJournal of Cardiovascular Pharmacology, 1994
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994